Financial Results : Jamjoom Pharma H1 2024 net profit rises to SAR 209.9M; Q2 at SAR 106.7M

Jamjoom Pharma H1 2024 net profit rises to SAR 209.9M; Q2 at SAR 106.7M

06/08/2024 Argaam Exclusive

View other reports

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) reported a net profit of SAR 209.9 million in H1 2024, an increase of 23% from SAR 170.7 million in the year-earlier period. 



Financials (M)

Item 6m 2023 6m 2024 Change‬
Revenues 599.25 731.20 22.0 %
Gross Income 397.70 467.59 17.6 %
Operating Income 186.47 230.84 23.8 %
Net Income 171.98 209.92 22.1 %
Average Shares 70.00 70.00 -
Earnings Per Share before unusual items (Riyals) 2.46 3.00 22.1 %
EPS (Riyals) 2.46 3.00 22.1 %

The company cited higher revenue, offset by cost of sales, but was further improved through cost efficiencies in other operating expenses, and other income. 



Current Quarter Comparison (M)

Compared With The
Item Q2 2023 Q2 2024 Change‬
Revenues 298.40 345.74 15.9 %
Gross Income 198.10 218.18 10.1 %
Operating Income 92.56 104.26 12.6 %
Net Income 86.27 106.95 24.0 %
Average Shares 70.00 70.00 -
Earnings Per Share before unusual items (Riyals) 1.23 1.53 24.0 %
EPS (Riyals) 1.23 1.53 24.0 %

Q2 2024 net profit reached SAR 107 million, up 24% from SAR 86.2 million in the year-earlier period, spurred by revenue growth, improved cost management and efficiency, as well as other income. 

 

On a quarterly basis, Q2 2024 net earnings grew 3.9% from SAR 102.9 million in Q1 2024. 

 

Total shareholders’ equity (no minority interest) reached SAR 1.46 billion by June 30, 2024, compared to SAR 1.35 billion in the corresponding period of the year before. 

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.